This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Ionis Pharmaceuticals, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Meghdad Rahdar: Innovator in CRISPR Technology
Introduction
Meghdad Rahdar is a prominent inventor based in San Diego, California. He has made significant contributions to the field of genetic engineering, particularly through his work with CRISPR technology. His innovative approach has led to advancements that could have far-reaching implications in various scientific domains.
Latest Patents
Meghdad Rahdar holds a patent for "Modified CRISPR RNA and modified single CRISPR RNA and uses thereof." This patent provides compounds comprising modified oligonucleotides for use in CRISPR. In certain embodiments, these modified oligonucleotides offer improved properties of crRNA and scrRNA, enhancing the effectiveness of CRISPR applications.
Career Highlights
Rahdar is currently associated with Ionis Pharmaceuticals, Inc., where he continues to push the boundaries of genetic research. His work is characterized by a commitment to innovation and a focus on practical applications of CRISPR technology.
Collaborations
Some of his notable coworkers include Thazha P Prakash and Eric E Swayze, who share a dedication to advancing the field of genetic engineering.
Conclusion
Meghdad Rahdar's contributions to CRISPR technology exemplify the potential of innovative research in genetics. His work not only enhances our understanding of genetic manipulation but also paves the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile